Chronic inflammatory demyelinating polyneuropathy associated with malignant melanoma
- 1 March 1996
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Neurology
- Vol. 46 (3), 822-824
- https://doi.org/10.1212/wnl.46.3.822
Abstract
(CIDP) is an acquired autoimmune disorder of unknown cause. CIDP most often occurs alone and not as a complication of other disorders but may accompany osteosclerotic myeloma and other plasma cell dyscrasias, human immunodeficiency virus (HIV) infection, and, rarely, systemic lupus erythematosus (SLE). [1] CIDP has not been associated with solid tumors and is not considered a direct or remote effect of cancer.Keywords
This publication has 9 references indexed in Scilit:
- Demyelinating neuropathies triggered by melanoma immunotherapyNeurology, 1994
- Regional and Systemic Strategies for Metastatic Malignant MelanomaMayo Clinic Proceedings, 1989
- Acquired inflammatory demyelinating polyneuropathies: Clinical and electrodiagnostic featuresMuscle & Nerve, 1989
- Antibodies to GM1 and GD1b in patients with motor neuron disease without plasma cell dyscrasiaAnnals of Neurology, 1989
- Gangliosides of human melanomaCancer, 1989
- Prognostic significance of hypopigmentation in malignant melanomaArchives of Dermatology, 1987
- Myelin‐Associated Glycoprotein Shares an Antigenic Determinant with a Glycoprotein of Human Melanoma CellsJournal of Neurochemistry, 1986
- Anti‐MAG IgM antibodies in patients with neuropathy and IgM M proteinsNeurology, 1983
- GANGLIOSIDES OF PERIPHERAL NERVE MYELINJournal of Neurochemistry, 1976